Quality of life and its determinants for heroin addicts receiving a methadone maintenance program: Comparison with matched referents from the general population

Journal of the Formosan Medical Association

Volumn 115, Issue 9, 2016, Pages 714-727

  Lin, Chung Ying ^a   Chang, Kun Chia ^b   Wang, Jung Der ^a,c   Lee, Lukas Jyuhn Hsiarn ^d,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Ministry of Health and Welfare   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

heroin abuse; human immunodeficiency virus; methadone maintenance treatment; quality of life

Indexed keywords

METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENVIRONMENTAL PARAMETERS; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE; SOCIAL BEHAVIOR; COMORBIDITY; COMPARATIVE STUDY; COMPLICATION; FACTUAL DATABASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPIATE SUBSTITUTION TREATMENT; QUESTIONNAIRE; REGRESSION ANALYSIS; TAIWAN; WORLD HEALTH ORGANIZATION;

ADULT; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPIATE SUBSTITUTION TREATMENT; QUALITY OF LIFE; REGRESSION ANALYSIS; SURVEYS AND QUESTIONNAIRES; TAIWAN; WORLD HEALTH ORGANIZATION;

EID: 84945557380     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.07.007     Document Type: Article

References (41)

1. 1 Chang, K.C., Lin, C.Y., Effects of publicly-funded and quality of life on attendance rate among methadone maintenance treatment patients in Taiwan: an 18-month follow-up study. Harm Reduct J, 2015 Accepted.
2. 2 Hser, Y.I., Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 26 (2007), 51–60.
3. 3 Degenhardt, L., Charlson, F., Mathers, B., Hall, W.D., Flaxman, A.D., Johns, N., et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction 109 (2014), 1320–1333.
4. 4 Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106 (2010), 32–51.
5. 5 Oppenhelmer, E., Tobutt, C., Taylor, C., Andrew, T., Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 89 (1994), 1299–1308.
6. 6 Wang, P.W., Wu, H.C., Yen, C.N., Yeh, Y.C., Chung, K.S., Chang, H.C., et al. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Psychol Addict Behav 26 (2012), 145–150.
7. 7 Che, Y., Assanangkornchai, S., McNeil, E., Li, J., You, J., Chongsuvivatwong, V., Patterns of attendance in methadone maintenance treatment program in Yunnan Province, China. Am J Drug Alcohol Abuse 37 (2011), 148–154.
8. 8 Hubbard, R.L., Craddock, S.G., Flynn, P.M., Anderson, J., Etheridge, R.M., Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 11 (1997), 261–278.
9. 9 Puigdollers, E., Domingo-Salvany, A., Brugal, M.T., Torrens, M., Alvarós, J., Castillo, C., et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 39 (2004), 1353–1368.
10. 10 Yang, F., Lin, P., Li, Y., He, Q., Long, Q., Fu, X., et al. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm Reduct J, 10, 2013, 3.
11. 11 Clausen, T., Anchersen, K., Waal, H., Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend 94 (2008), 151–157.
12. 12 Farré, M., Mas, A., Torrens, M., Moreno, V., Camí, J., Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 65 (2002), 283–290.
13. 13 Marsch, L.A., The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93 (1998), 515–532.
14. 14 Chien, I.C., Chang, K.C., Lin, C.H., Chou, Y.J., Chou, P., Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study. Gen Hosp Psychiatry 32 (2010), 138–141.
15. 15 Chien, I.C., Chou, Y.J., Lin, C.H., Prevalence of psychiatric disorders among national health insurance enrollees in Taiwan. Psychiatr Serv 55 (2004), 691–697.
16. 16 Ko, N.Y., Wang, P.W., Wu, H.C., Yen, C.N., Hsu, S.T., Yeh, Y.C., et al. Self-efficacy and HIV risk behaviors among heroin users in Taiwan. J Stud Alcohol Drugs 73 (2012), 469–476.
17. 17 Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L.A., Sarang, A., Rylkov, A., et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 16 (2002), F25–31.
18. 18 Chen, Y.M., Kuo, S.H., HIV-1 in Taiwan. Lancet 369 (2007), 623–625.
19. 19 Su, C.T., Ng, H.S., Yang, A.L., Lin, C.Y., Psychometric evaluation of the Short Form 36 Health Survey (SF-36) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) for patients with schizophrenia. Psychol Assess 26 (2014), 980–989.
20. 20 Bobes, J., García-Portilla, P., Sáiz, P.A., Bascarán, T., Bousoño, M., Quality of life measures in schizophrenia. Eur Psychiatry 20 (2005), S313–S317.
21. 21 Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., Alonso, J., Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 92 (1997), 707–716.
22. 22 Astals, M., Domingo-Salvany, A., Buenaventura, C.C., Tato, J., Vazquez, J.M., Martin-Santos, R., et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse 43 (2008), 612–632.
23. 23 Deng, C.F., Ma, X., Zhou, H., Liu, Q.L., Yang, Y., Song, Z., et al. Quality of life of heroin dependent patients with methadone maintenance therapy. Sichuan Da Xue Xue Bao Yi Xue Ban 40 (2009), 539–543.
24. 24 Korthuis, P.T., Zephyrin, L.C., Fleishman, J.A., Saha, S., Josephs, J.S., McGrath, M.M., et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDs 22 (2008), 859–867.
25. 25 Lin, S.H., Chen, K.C., Lee, S.Y., Hsiao, C.Y., Lee, I.H., Yeh, T.L., et al. The economic cost of heroin dependency and quality of life among heroin users in Taiwan. Psychiatry Res 209 (2013), 512–517.
26. 26 Yen, C.N., Wang, C.S.M., Wang, T.Y., Chen, H.F., Chang, H.C., Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci 27 (2011), 177–183.
27. 27 American Psychiatric Association, Diagnostic and statistical manual of mental disorders, 4th ed., Author; Washington, DC.
28. 28 Hung, Y.T., Sampling design of the National Health Interview Survey. NHIS Brief Communication No. 2. 2002, National Health Interview Survey, Taipei, Taiwan.
29. 29 Lin, S.H., Field collection and completeness of data in the National Health Interview Survey. NHIS Brief Communication No. 4. 2002, National Health Interview Survey, Taipei, Taiwan.
30. 30 Lee, L.J.H., Chung, C.W., Chang, Y.Y., Lee, Y.C., Yang, C.H., Liou, S.H., et al. Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls. Qual Life Res 20 (2011), 415–423.
31. 31 Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 (2007), 175–191.
32. 32 Yao, G., Chung, C.W., Yu, C.F., Wang, J.D., Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 101 (2002), 342–351.
33. 33 The WHOQOL-Taiwan Group, Development of the World Health Organization Quality of Life Scale Brief Version, Taiwan, version, and using manual. 2nd ed., 2005, The WHOQOL-Taiwan Group, Taipei, Taiwan.
34. 34 Chang, K.C., Wang, J.D., Tang, C.P., Cheng, C.M., Lin, C.Y., Psychometric evaluation, using Rasch analysis, of the WHOQOL-BREF in heroin-dependent people undergoing methadone maintenance treatment: further item validation. Health Qual Life Outcomes, 12, 2014, 148.
35. 35 Su, C.T., Wang, J.D., Lin, C.Y., Child-rated versus parent-rated quality of life of community-based obese children across gender and grade. Health Qual Life Outcomes, 11, 2013, 206.
36. 36 Portney, L.G., Watkins, M.P., Foundations of clinical research: Applications to practice. 2nd ed., 2000, Prentice Hall Health, Upper Saddle River, New Jersey.
37. 37 De Maeyer, J., Vanderplasschen, W., Broekaert, E., Quality of life among opiate-dependent individuals: a review of the literature. Int J Drug Policy 21 (2001), 364–380.
38. 38 Wallance, A.E., Weeks, W.B., Wang, S., Lee, A.F., Kazis, L.E., Rural and urban disparities in health-related quality of life among veterans with psychiatric disorders. Psychiatr Serv 57 (2006), 851–856.
39. 39 Weeks, W.B., Kazis, L.E., Shen, Y., Cong, Z., Ren, X.S., Miller, D., et al. Differences in health-related quality of life in rural and urban veterans. Am J Public Health 94 (2004), 1762–1767.
40. 40 Parker, R., Aggleton, P., HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med 57 (2003), 13–24.
41. 41 Rasmusen, E., Stigma and self-fulfilling expectations of criminality. Journal of Law and Economics 39 (1996), 519–544.